Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H6N4O |
| Molecular Weight | 126.1168 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC(=O)N=C(N)N1
InChI
InChIKey=SWELIMKTDYHAOY-UHFFFAOYSA-N
InChI=1S/C4H6N4O/c5-2-1-3(9)8-4(6)7-2/h1H,(H5,5,6,7,8,9)
2,4-Diamino-6-hydroxypyrimidine is a selective, specific inhibitor of GTP cyclohydrolase I, a rate-limiting enzyme for the de novo biosynthesis of biopterin. Experiments in rats have shown that 4-Diamino-6-hydroxypyrimidine possesses protective effects against postburn Staphylococcus aureus sepsis.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P30793 Gene ID: 2643.0 Gene Symbol: GCH1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9694862 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| 2,6-Diamino-4-oxo-3,4-dihydropyrim-idin-1-ium chloride dihydrate. | 2010-08-11 |
|
| Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents. | 2010-07-15 |
|
| Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents. | 2010-05-15 |
|
| Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats. | 2010-05 |
|
| Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. | 2010-04-22 |
|
| Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry. | 2010-02-11 |
|
| Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats. | 2009-11 |
|
| DFT simulations and vibrational analysis of FT-IR and FT-Raman spectra of 2,4-diamino-6-hydroxypyrimidine. | 2009-08-15 |
|
| Highly diastereoselective domino synthesis of 6-spirosubstituted pyrido[2,3-d]pyrimidine derivatives in water. | 2009-06-23 |
|
| A facile synthetic approach to 7-deazaguanine nucleosides via a Boc protection strategy. | 2009-06-04 |
|
| Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. | 2009-06 |
|
| Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. | 2008-09 |
|
| Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats. | 2008-08 |
|
| Effect of decreased levels of intrinsic tetrahydrobiopterin on endothelial function in anesthetized rats. | 2008-05 |
|
| 2,4-Diamino-6-hydroxypyrimidine (DAHP) suppresses cytokine-induced VCAM-1 expression on the cell surface of human umbilical vein endothelial cells in a BH(4)-independent manner. | 2007-11-05 |
|
| Regulation of tetrahydrobiopterin biosynthesis by shear stress. | 2007-10-12 |
|
| Alu recombination-mediated structural deletions in the chimpanzee genome. | 2007-10 |
|
| An efficient route for the synthesis of a new class of pyrido[2,3-d]pyrimidine derivatives. | 2007-05-07 |
|
| C-Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation. | 2007 |
|
| Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. | 2006-04-29 |
|
| Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis. | 2006-01-20 |
|
| Neural tube closure depends on nitric oxide synthase activity. | 2006-01 |
|
| Synthesis and antitumor activity of some novel quinazoline derivatives bearing the biologically active thione moiety. | 2006 |
|
| Tetrahydrobiopterin depletion and ubiquitylation of neuronal nitric oxide synthase. | 2005-12-07 |
|
| Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke. | 2005-12 |
|
| Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. | 2005-10 |
|
| Crystal structure and luminescence of lanthanide monodentate complexes [Ln(C(4)N(4)H(6)O)(2)(H(2)O)(6)]Cl(3) and [Ln(C(4)N(4)H(6)O)(2)(H(2)O)(3)(NO(3))(3)] (Ln = Tb or Eu). | 2005-06-13 |
|
| Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates. | 2004-12-30 |
|
| Effect of tetrahydrobiopterin on nitric oxide synthase-containing cells in the rat hippocampus. | 2004-10 |
|
| The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: requirement of the GTP cyclohydrolase I feedback regulatory protein. | 2004-09-24 |
|
| A new and efficient synthesis of pyrrolo[2,3-d]pyrimidine anticancer agents: Alimta (LY231514, MTA), homo-Alimta, TNP-351, and some aryl 5-substituted pyrrolo[2,3-d]pyrimidines. | 2003-12-26 |
|
| Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells. | 2003-12-12 |
|
| Antiangiogenic and antitumor agents. Design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases. | 2003-11-17 |
|
| GTP cyclohydrolase 1 inhibition attenuates vasodilation and increases blood pressure in rats. | 2003-11 |
|
| Kainic acid lesion-induced nigral neuronal death. | 2003-08 |
|
| Exogenous biopterins requirement for iNOS function in vascular smooth muscle cells. | 2003-08 |
|
| Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. | 2003-06-20 |
|
| Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures. | 2003-04 |
|
| Increased vulnerability to ischemia/reperfusion-induced ventricular tachyarrhythmias by pre-ischemic inhibition of nitric oxide synthase in isolated rat hearts. | 2003-02-25 |
|
| HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. | 2003-02-01 |
|
| Wavelength-dependent induction of a mycosporine-like amino acid in a rice-field cyanobacterium, Nostoc commune: role of inhibitors and salt stress. | 2003-02 |
|
| Role of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts. | 2003-02 |
|
| Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-Diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies. | 2003-01-02 |
|
| Effect of 2,4-diamino-6-hydroxy-pyrimidine on postburn Staphylococcus aureus sepsis in rats. | 2002-11 |
|
| Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. | 2002-09 |
|
| Possible involvement of tetrahydrobiopterin in the trophic effect of insulin-like growth factor-1 on rat pheochromocytoma-12 (PC12) cells. | 2002-08-09 |
|
| Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. | 2002-05-02 |
|
| [The protective effects and its underlying mechanism of 2,4-diamino-6-hydroxy-pyrimidine on postburn Staphylococcus aureus sepsis in rats]. | 2002-04 |
|
| A new one-pot three-component condensation reaction for the synthesis of 5-deaza-5,8-dihydropterins. | 2001-12-07 |
|
| Guanosine triphosphate cyclohydrolase I regulates nitric oxide synthesis in renal proximal tubules. | 1995-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12441764
Male Wistar rats: animals were intraperitoneally injected with a dose of 1 g/kg 2,4-diamino-6-hydroxy-pyrimidine (DAHP) before Staphylococcus aureus challenge and then were further divided into 2- and 6-hr groups
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7537228
In interferon-gamma-activated murine peritoneal macrophages 2,4-diamino-6-hydroxy-pyrimidine suppresses the expression of iNOS mRNA and protein in a tetrahydrobiopterin (BH4)-independent manner and, thus, acts by a novel mechanism.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
135408763
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
100643-27-4
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
ALTERNATIVE | |||
|
680818
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
m4253
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID4049038
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
200-254-4
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
44914
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
C017202
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
56-06-4
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
EDH7CNS75I
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY | |||
|
9302
Created by
admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD